CASE REPORT
A 52-year-old Chinese woman presented to the endocrinology department with a series of medical complaints. She had progressive weight gain (with central obesity) despite having a rigorous exercise regimen, poorly controlled diabetes mellitus with easy bruisability and patchy hair-loss. She was also diagnosed with osteoporosis with dual-energy x-ray absorptiometry (DEXA) bone mineral densitometry (BMD) demonstrating a T-Score below -2.5. The attending endocrinologist performed a series of biochemical tests including urinary free cortisol (UFC) levels and dexamethasone-corticotropin-releasing hormone test, all of which were inconclusive. A computed tomography (CT) of the adrenal glands along with a magnetic resonance imaging (MRI) of the pituitary gland also failed to reveal an adrenal mass or a pituitary adenoma. Given the strong clinical suspicion of Cushing's disease and inconclusive work-up, after discussion with the treating endocrinologist and the patient, a unanimous decision was made to perform a bilateral inferior petrosal sinus sampling (BIPSS) to confirm the diagnosis of Cushing's disease.
Before the procedure, the patient fasted overnight. Informed consent was also obtained prior to the procedure after explanation of the procedure, possible risks and complications. BIPSS was then performed after obtaining intravenous access via the bilateral common femoral veins (CFVs) using Seldinger technique with a 6 French Terumo Vascular Sheath (Terumo Corporation, Tokyo). The right femoral sheath was intended for the right jugular catheterization and the same for the left to prevent confusion during the sample collection. A 5 French Torcon NB Advantage Beacon tip catheter with DAV tip configuration (Cook Medical, Bloomington, Indiana) and a 0.035-inch hydrophilic straight Terumo guidewire (Terumo Corporation, Tokyo) was used for catheterization of the internal jugular veins (IJVs). Under fluoroscopic guidance, the inferior vena cava, right atrium and superior vena cava (SVC) were crossed. The catheter was then manipulated into the right brachiocephalic vein and finally the right IJV. About 10 ml of Iohexol (Omnipaque 350; GE Healthcare) was hand injected at the level of the superior bulb of the right IJV to opacify its tributaries, namely the inferior petrosal sinus (IPS) (Fig. 1) . A roadmap to mark the ostium of the IPS was also obtained at this stage. A 2.5 French Cantata super-selective microcatheter (Cook Medical, Bloomington, Indiana) was then introduced coaxially through the 5 French catheter; with its tip parked at the level of the IPS ostium. With the help of the microwire, the IPS was then entered followed by the microcatheter. A gentle venogram was performed through the microcatheter after removal of the microwire with a 2 ml Luer lock syringe. Demonstrating the reflux of contrast media into the ipsilateral cavernous sinus indicates a correct position of the microcatheter within the IPS.
After we experienced difficulties in entering and crossing the left brachiocephalic vein, a venogram was performed. It revealed a small rudimentary left brachiocephalic vein and a persistent left SVC draining into the coronary sinus (Fig. 2) . The left-sided IPS was therefore entered via the right atrium, coronary sinus, persistent left SVC and the left IJV (Figs. 3  and 4 ).
Once the microcatheters were in position (Fig. 5) , simultaneous venous blood samples were obtained from each sites, including the both inferior petrosal sinuses and the peripheral sites (which were obtained via the vascular sheaths). Once the baseline samples (usually two sets of baseline samples) were obtained, corticotropin-releasing hormone (CRH) was injected peripherally as a slow bolus at 1 mcg/kg (maximum 100 mcg). The post-CRH samples were obtained from each port at 2, 5, 10, and 15 minutes. Post sampling, the catheters and sheaths were removed, and manual pressure was applied at the bilateral groin sites until venous hemostasis was achieved. In our index case, the procedure was uneventful and the patient was discharged the next day.
Subsequently the BIPSS results in our index case not only confirmed the diagnosis of Cushing's disease but also localized the hormonally active microadenoma in the right side of her pituitary gland.
Efforts to measure the pituitary venous effluent was first reported by Corrigan and colleagues in 1977 [1] . Since then, the technique has been refined and standardized by various investigators and currently it a very useful tool used by the endocrinologist for the evaluation of Cushing's syndrome, especially when the usual battery of biochemical tests and cross-sectional imaging are negative or inconclusive.
Etiology & Demographics Cushing's syndrome:
Although the most common cause of Cushing's syndrome is exogenous intake of glucocorticoid, we shall be discussing only about the endogenous causes of Cushing's syndrome; which may be due to adrenocorticotropic hormone (ACTH) dependent causes like excessive ACTH production from a pituitary microadenoma (Cushing's disease), ectopic ACTH secretion by a non-pituitary tumor, or ACTH independent excessive autonomous secretion of cortisol from a hyperfunctioning adrenocortical tumor [2] .
Cushing's syndrome is a very rare entity with an annual incidence of 2 to 4 cases per million [3] . Cushing's disease is the most frequent cause of Cushing's syndrome, with an annual incidence of between 1.2 to 2.4 cases per million. It is also 3-8 times higher in women than in men [3] .
Double superior vena cava:
Double SVC is a rare congenital venous anomaly with a reported frequency of about 0.3 to 0.5% in the general population and about 4% of patients with congenital heart disease. Normally the right anterior cardinal and common cardinal veins form the SVC, and the left anterior cardinal vein regresses during fetal development. In case of double SVC, the left anterior cardinal vein fails to regress and persists. On the other hand, the regression of the normally persistent right cardinal vein would result in the formation of a left SVC [4] .
Clinical & Imaging findings
Cushing's syndrome: Cushing's syndrome can present with a myriad of nonspecific symptoms and signs such as weakness, lethargy, weight gain, menstrual irregularities, depression, loss of libido, acne, purplish skin striae, hyperpigmentation, thinning of skin and easy bruising. It can also present with more suggestive features like proximal myopathy, new onset or worsening of diabetes mellitus or hypertension (despite measures to control them), osteoporosis and hirsutism. Cushing's disease may also cause symptoms related to mass effect from the tumor such as headache or visual disturbances, namely bitemporal hemianopia (due to compression of the optic chiasm).
Clinicians heavily rely on biochemical testing to narrow down their differential diagnosis of Cushing's syndrome, after which a targeted cross-sectional imaging of either the pituitary or adrenals glands is performed. Since adrenocorticotropic hormone (ACTH) dependent Cushing's syndrome is secondary to a pituitary microadenoma (Cushing's disease) in about 90% of patients, the pretest probability of Cushing's disease is also about 90% [2, 5] . Therefore, pituitary imaging is commonly utilized to detect and localize the position of a pituitary microadenoma. It is also used as a guide for surgical exploration. A contrast-enhanced MR is favored over CT, due to the poor sensitivity (reported to be about 47%) of the latter for the detection of pituitary microadenomas [3] . The quoted sensitivity of MRI in some series ranged between 69 to 90% [5] . Dynamic contrast-enhanced thin section T1-weighted MR is ideally performed for the detection of microadenomas, as they usually display a hypointense signal intensity due to failure to rapidly enhance in relation to the avidly enhancing pituitary gland. However, approximately 5% of these pituitary microadenomas will also rapidly take up the gadolinium contrast media, thus giving an isointense signal on MRI with resultant failure to visualize these lesions [6] . This is further compounded by the fact that detection of a pituitary microadenoma on MR does not confirm its functionality, since 10% of the general population harbors non-functioning incidentalomas [2, 3] . Role of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing's disease in a patient with double superior vena cava
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Therefore, bilateral inferior petrosal sinus sampling (BIPSS) has a role in differentiating between Cushing's disease and the other causes of Cushing's syndrome with confidence. The reported sensitivities and specificities are 95% and 100%, respectively, without CRH stimulation and 100% and 100%, respectively, after CRH stimulation for BIPSS [7] . It can also be used for lateralizing small hormone-producing adenomas within the pituitary gland, as in approximately 60% of individuals, pituitary venous drainage is symmetrical with most of the venous effluent from each side of the pituitary draining into the ipsilateral IPS [8] .
Double superior vena cava
In the absence of congenital heart disease, double SVC or duplication of SVC is usually detected incidentally on either cross-sectional imaging or on radiograph, when traversed by a left-sided central venous catheter or during the introduction of cardiac pacemaker and defibrillator wires; where it courses along the left side of mediastinum towards the heart. In these cases, the left component of the duplicated SVC almost always drains into the coronary sinus [4] with no physiologic impact on circulation. This finding in our index case is also incidental and has no known association with Cushing's disease.
Anatomy of the inferior petrosal sinus
The inferior petrosal sinus (IPS) connects the posteroinferior part of the cavernous sinus to the superior bulb of the internal jugular vein (IJV) via the petroclival fissure. Various patterns of confluence with the IJV are described in the literature. In majority, the IPS narrows down to a single vein (about 2 mm in diameter), draining into the ipsilateral IJV. In about 25%, the IPS "forms plexiform channels" that drains into the IJV [9] and in about 1%, there is no connection between the IPS and the IJV making standard sampling impossible [8, 10] . The latter information needs to be relayed to the patient during consent taking.
Techniques & Complications of BIPSS
The entry into the left IJV is often described as difficult as opposed to the right IJV, due to the presence of a valve at the junction of the left IJV and left subclavian vein. In our case, this problem was rather circumvented, as the patient was incidentally found to have a double SVC, which imposed another technical challenge, as the coronary sinus draining into the right atrium needed to be catheterized to get access to the left IJV and left IPS.
After accessing the IPS, a gentle venogram should be performed not only to confirm the position of the microcatheter within the IPS but also to check for communication with ipsilateral cavernous sinus. The position of the microcatheter should also be well within the IPS to prevent its dislodgement.
In the rare event of absent communication between the IPS and IJV, the catheters can be placed at the C1-2 levels for sampling. However, sampling at this level may be associated with false results due to contamination from the transverse or sigmoid sinuses.
Deep catheterization or entry into the cavernous sinus is not required or recommended, as cavernous sinus sampling has no superior diagnostic accuracy compared to IPS sampling. It is also technically more challenging with increased risk of complications. Some authors [8, 9] advocate the infusion of intravenous heparin after the IPS is accessed by the microcatheters, but this can be avoided as in our case with periodic gentle flushes of saline via the microcatheter to maintain its patency and prevent clot formation around the catheter tip.
Larger sized vascular sheaths should be used when accessing the venous system as they help in the simultaneous collection of peripheral venous blood samples during the BIPSS.
Teamwork is a crucial element especially at the stage of collecting the venous samples, as each member should know the timing and the site/side of the venous samples obtained. The samples must also be placed immediately into properly labeled purple/lavender-top EDTA-containing tubes and stored on ice (for serum ACTH levels).
The most common complication during the BIPSS procedure is groin hematoma, seen in about 3-4% of the patients [8,9]. The incidence of serious complications like cerebrovascular accident (usually pontocerebellar junction stroke) is very low at 2 per 1000 cases when performed by an experienced intervention radiologist [11] . The cause of this complication is not clearly understood but is presumed to be due to localized venous hypertension [11] .
Therefore, during the entire procedure the patient must be closely monitored to look for signs of brain stem stroke: slurred speech, hemifacial paresthesia, perioral tingling sensation, and labile hypertension. The procedure should be immediately terminated, in the event the patient develops such signs. So only light sedation and anxiolysis is recommended for this procedure. Very rarely deep venous thrombosis, pulmonary embolism, transient cranial nerve palsies, and venous subarachnoid hemorrhage with obstructive hydrocephalus have been reported [9] .
Results in our index case
The BIPSS results (table 4) obtained from our index case confirmed the clinical suspicion of Cushing's disease. The results revealed a high petrosal sinus to peripheral vein ACTH ratio, exceeding 3:1, confirming a pituitary source of ACTH excess. It also revealed a right petrosal sinus to left petrosal sinus ACTH lateralization ratio of 5.2, successfully localizing the ACTH excess to be from the right side of the patient's pituitary gland. The criterion for lateralization is a side-to-side gradient ≥ 1.4 post-CRH stimulation. A gradient < 1.4 indicates a midline lesion with an approximate accuracy of 70% [7] . The prolactin levels were taken as a control to indicate the correct cannulation of the petrosal sinuses, as they corresponded with the ACTH levels in the respective sites.
Treatment & Prognosis
The treatment of choice for Cushing's disease is transsphenoidal selective adenomectomy with a remission rate ranging from 69 to 98% (simple average 79%), recurrence rate from 3 to 17% (simple average 10%), and the acute surgical mortality rate from 0 to 1.9% [12] .
Medical therapy is also employed non-concurrently or as an adjuvant to radiation therapy for patients who are either poor surgical candidates or those with failed surgery. It is also used as a temporizing measure preoperatively. Numerous drugs with various mechanism of actions, such as neuromodulation to limit ACTH levels, adrenal enzyme inhibition, and glucocorticoid receptor antagonism are used with varying results and side-effects [13] .
Differential Diagnoses
Although Cushing's disease is the most common cause of endogenous Cushing's syndrome, differentiating it from the other causes is of paramount importance as their treatments are radically different [2] .
A cortisol-secreting adrenal tumor, usually an adenoma, needs to be excluded in the diagnostic workup of Cushing's syndrome. Dedicated CT or MR can be used to detect and characterize an adrenal adenoma. Adrenal adenomas are welldefined nodules with an average attenuation of less than 10 Hounsfield unit (HU) for a lipid-rich adenoma and more than 10HU for a lipid-poor adenoma on unenhanced CT. Since an adenoma enhances rapidly with intravenous contrast media and washes out the agent rapidly also, a dynamic contrastenhanced CT or MR should show a wash-out value of more than 50% [14] . Its T1-weighted and T2-weighted signals on MR is variable but in case of lipid-rich adenomas, chemical shift imaging can be used to demonstrate a signal "drop out" in the out-of-phase images, i.e., appearing hypointense than the in-phase images [14] . Since a unilateral cortisol-secreting adrenal tumor will result in suppression of ACTH secretion, the remaining ipsilateral and contralateral adrenal gland may be atrophic in appearance [2] .
Various non-pituitary tumors are known for causing ectopic secretion of ACTH. Small-cell lung cancer and bronchial carcinoid tumors are the most common sources, but cases of medullary thyroid carcinoma, pancreatic carcinoid tumor, thymic carcinoid tumor and disseminated carcinoid are also documented to be ectopic sources of ACTH. Although dedicated imaging of these organs or sites can be performed for detection and further characterization, many carcinoid tumors, small-cell lung cancers, and medullary thyroid carcinoma have been found to express high numbers of somatostatin receptors [15] . Therefore, with the recent advent of somatostatin receptor imaging, these lesions can be identified with a higher degree of sensitivity and specificity [16] .
In patients with a clinical suspicion of Cushing's disease without a suggestive pituitary lesion on magnetic resonance imaging (MRI), bilateral inferior petrosal sinus sampling (BIPSS) provides excellent specificity and higher sensitivity than the other currently available biochemical testing strategies and despite its invasive nature, the complication rates are low when performed by a trained interventionist. Double superior vena cava (SVC) has no known association with Cushing's disease, but the presence of such congenital venous anomaly makes the procedure of bilateral inferior petrosal sinus sampling (BIPSS) technically more challenging, therefore having a sound anatomical knowledge of such rare venous anomaly is paramount for the procedure to be performed safely and successfully. 
Prognosis
 Surgery has remission rate ranging from 69 to 98% (simple average 79%), recurrence rate from 3 to 17% (simple average 10%), and the acute surgical mortality rate from 0 to 1.9%.  No specific data are available for medical and radiation therapy.
Findings on imaging
 Hypodense or hypointense lesion on dynamic contrast-enhanced CT or MR. CT has a low sensitivity of about 47%. Sensitivity for MRI ranged between 69 to 90%.  Positive BIPSS results for radiologically occult hormonally active pituitary microadenomas. Findings on imaging  Usually found incidentally on either cross-sectional imaging or on radiograph, when traversed by a central venous catheter or during the introduction of cardiac pacemaker and defibrillator wires; where it courses along the left side of mediastinum towards the heart. 
Adrenal adenoma
 Well-defined nodules with an average attenuation of less than 10 HU for a lipid-rich adenoma and more than 10HU for a lipid-poor adenoma on unenhanced CT.  Wash-out value of more than 50% on a dynamic contrast enhanced CT or MR.  Signal "drop out" in the out-of-phase MR sequences for a lipid-rich adenoma.  In case of unilateral hormonally active adrenal adenoma, the remaining ipsilateral and contralateral adrenal gland may be atrophic in appearance. Ectopic secretion of ACTH, from small-cell lung cancer, bronchial carcinoid tumors, medullary thyroid carcinoma, pancreatic carcinoid tumor, thymic carcinoid tumor and disseminated carcinoid.
 Dedicated US, CT and MR of these organs sites can be performed for their detection.  Positive uptake of radiotracer in somatostatin receptor imaging. 
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